Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
EMBO J. 1998 Apr 1;17(7):2008-18.

Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.

Author information

  • 1Istituto di Patologia Generale e Oncologia, Facolt√† di Medicina e Chirurgia, II Universit√† di Napoli, Largo S.Aniello a Caponapoli, 2, 80138 Napoli, Italy.

Abstract

The molecular mechanisms by which ovarian hormones stimulate growth of breast tumors are unclear. It has been reported previously that estrogens activate the signal-transducing Src/p21(ras)/Erk pathway in human breast cancer cells via an interaction of estrogen receptor (ER) with c-Src. We now show that progestins stimulate human breast cancer T47D cell proliferation and induce a similar rapid and transient activation of the pathway which, surprisingly, is blocked not only by anti-progestins but also by anti-estrogens. In Cos-7 cells transfected with the B isoform of progesterone receptor (PRB), progestin activation of the MAP kinase pathway depends on co-transfection of ER. A transcriptionally inactive PRB mutant also activates the signaling pathway, demonstrating that this activity is independent of transcriptional effects. PRB does not interact with c-Src but associates via the N-terminal 168 amino acids with ER. This association is required for the signaling pathway activation by progestins. We propose that ER transmits to the Src/p21(ras)/Erk pathway signals received from the agonist-activated PRB. These findings reveal a hitherto unrecognized cross-talk between ovarian hormones which could be crucial for their growth-promoting effects on cancer cells.

PMID:
9524123
[PubMed - indexed for MEDLINE]
PMCID:
PMC1170546
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk